Found: 35
Select item for more details and to access through your institution.
A Case of Acute Kidney Injury Associated With Dabrafenib and Trametinib Treatment for Metastatic Melanoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Pharmacist-Urologist Collaborative Management Improves Clinical Outcomes in Patients With Castration-Resistant Prostate Cancer Receiving Enzalutamide.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.901099
- By:
- Publication type:
- Article
Analysis of the variable factors influencing tacrolimus blood concentration during the switch from continuous intravenous infusion to oral administration after allogeneic hematopoietic stem cell transplantation.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Risk evaluation of denosumab and zoledronic acid for medication-related osteonecrosis of the jaw in patients with bone metastases: a propensity score–matched analysis.
- Published in:
- Supportive Care in Cancer, 2022, v. 30, n. 3, p. 2341, doi. 10.1007/s00520-021-06634-7
- By:
- Publication type:
- Article
Associated characteristics and treatment outcomes of medication-related osteonecrosis of the jaw in patients receiving denosumab or zoledronic acid for bone metastases.
- Published in:
- Supportive Care in Cancer, 2021, v. 29, n. 8, p. 4763, doi. 10.1007/s00520-021-06018-x
- By:
- Publication type:
- Article
Author Correction: Analysis of chemotherapy-induced peripheral neuropathy using the Japanese Adverse Drug Event Report database.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Stability of cetuximab and panitumumab in glass vials and polyvinyl chloride bags.
- Published in:
- American Journal of Health-System Pharmacy, 2010, v. 67, n. 3, p. 223, doi. 10.2146/ajhp090031
- By:
- Publication type:
- Article
Monitoring for potential adverse drug reactions in patients receiving chemotherapy.
- Published in:
- American Journal of Health-System Pharmacy, 2004, v. 61, n. 22, p. 2366, doi. 10.1093/ajhp/61.22.2366
- By:
- Publication type:
- Article
Safety and blood levels of daratumumab after switching from intravenous to subcutaneous administration in patients with multiple myeloma.
- Published in:
- Investigational New Drugs, 2023, v. 41, n. 5, p. 761, doi. 10.1007/s10637-023-01392-1
- By:
- Publication type:
- Article
Impact of prior bevacizumab therapy on the incidence of ramucirumab-induced proteinuria in colorectal cancer: a multi-institutional cohort study.
- Published in:
- International Journal of Clinical Oncology, 2023, v. 28, n. 8, p. 1054, doi. 10.1007/s10147-023-02357-3
- By:
- Publication type:
- Article
Analysis of Drug-Induced Gastrointestinal Obstruction and Perforation Using the Japanese Adverse Drug Event Report Database.
- Published in:
- Frontiers in Pharmacology, 2021, v. 12, p. 1, doi. 10.3389/fphar.2021.692292
- By:
- Publication type:
- Article
Antiemetic effectiveness and safety of aprepitant in patients with hematologic malignancy receiving multiday chemotherapy.
- Published in:
- American Journal of Health-System Pharmacy, 2013, v. 70, n. 4, p. 343, doi. 10.2146/ajhp120363
- By:
- Publication type:
- Article
Evaluating the safety and efficiency of robotic dispensing systems.
- Published in:
- Journal of Pharmaceutical Health Care & Sciences, 2022, v. 8, n. 1, p. 1, doi. 10.1186/s40780-022-00255-w
- By:
- Publication type:
- Article
Polypharmacy-associated potential contraindications of drug prescriptions in patients with primary angle closure disease in a real-world setting.
- Published in:
- Journal of Pharmaceutical Health Care & Sciences, 2021, v. 7, n. 1, p. 1, doi. 10.1186/s40780-021-00196-w
- By:
- Publication type:
- Article
Effectiveness of Pharmacist–Physician Collaborative Management for Patients With Idiopathic Pulmonary Fibrosis Receiving Pirfenidone.
- Published in:
- Frontiers in Pharmacology, 2020, v. 11, p. N.PAG, doi. 10.3389/fphar.2020.529654
- By:
- Publication type:
- Article
Population pharmacokinetics of tacrolimus in umbilical cord blood transplant patients focusing on the variation in red blood cell counts.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2021, v. 46, n. 1, p. 190, doi. 10.1111/jcpt.13279
- By:
- Publication type:
- Article
Evaluation of the usefulness of protocol‐based pharmacist‐facilitated laboratory monitoring to ensure the safety of immune checkpoint inhibitors in patients with lung cancer.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2020, v. 45, n. 6, p. 1288, doi. 10.1111/jcpt.13207
- By:
- Publication type:
- Article
Effect of the number of dose adjustment factors on bleeding risk in patients receiving 30 mg/day edoxaban.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2020, v. 45, n. 2, p. 298, doi. 10.1111/jcpt.13065
- By:
- Publication type:
- Article
Implementation of institutional antiemetic guidelines for low emetic risk chemotherapy with docetaxel: a clinical and cost evaluation.
- Published in:
- Supportive Care in Cancer, 2012, v. 20, n. 8, p. 1805, doi. 10.1007/s00520-011-1278-6
- By:
- Publication type:
- Article
Risk Factors for Predicting Severe Neutropenia Induced by Amrubicin in Patients with Advanced Lung Cancer.
- Published in:
- Chemotherapy (0009-3157), 2013, v. 58, n. 6, p. 419, doi. 10.1159/000345617
- By:
- Publication type:
- Article
Osteonecrosis of the Jaw Caused by Denosumab in Treatment-Naïve and Pre-Treatment with Zoledronic Acid Groups: A Time-to-Onset Study Using the Japanese Adverse Drug Event Report (JADER) Database.
- Published in:
- Drugs - Real World Outcomes, 2022, v. 9, n. 4, p. 659, doi. 10.1007/s40801-022-00324-4
- By:
- Publication type:
- Article
Involvement of spinal NR2B-containing NMDA receptors in oxaliplatin-induced mechanical allodynia in rats.
- Published in:
- Molecular Pain, 2011, v. 7, n. 1, p. 1, doi. 10.1186/1744-8069-7-8
- By:
- Publication type:
- Article
Risk factors of proteinuria and potentially protective effect of renin–angiotensin system inhibitors in patients with renal cell carcinoma receiving axitinib.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2022, v. 89, n. 6, p. 833, doi. 10.1007/s00280-022-04408-4
- By:
- Publication type:
- Article
Switching from zoledronic acid to denosumab increases the risk for developing medication-related osteonecrosis of the jaw in patients with bone metastases.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Incidence and risk factors for paclitaxel hypersensitivity during ovarian cancer chemotherapy.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2005, v. 56, n. 1, p. 91, doi. 10.1007/s00280-004-0924-9
- By:
- Publication type:
- Article
Assessment of Reye's syndrome profile with data from the US Food and Drug Administration Adverse Event Reporting System and the Japanese Adverse Drug Event Report databases using the disproportionality analysis.
- Published in:
- SAGE Open Medicine, 2020, p. 1, doi. 10.1177/2050312120974176
- By:
- Publication type:
- Article
Assessment of Reye's syndrome profile with data from the US Food and Drug Administration Adverse Event Reporting System and the Japanese Adverse Drug Event Report databases using the disproportionality analysis.
- Published in:
- SAGE Open Medicine, 2020, v. 8, p. 1, doi. 10.1177/2050312120974176
- By:
- Publication type:
- Article
Population pharmacokinetics and exposure–clinical outcome relationship of remdesivir major metabolite GS‐441524 in patients with moderate and severe COVID‐19.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2023, v. 12, n. 4, p. 513, doi. 10.1002/psp4.12936
- By:
- Publication type:
- Article
Population pharmacokinetics of favipiravir in patients with COVID‐19.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2021, v. 10, n. 10, p. 1161, doi. 10.1002/psp4.12685
- By:
- Publication type:
- Article
Analysis of chemotherapy-induced peripheral neuropathy using the Japanese Adverse Drug Event Report database.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-90848-6
- By:
- Publication type:
- Article
Efficacy and Safety of Aprepitant in Allogeneic Hematopoietic Stem Cell Transplantation.
- Published in:
- Pharmacotherapy, 2013, v. 33, n. 9, p. 893, doi. 10.1002/phar.1294
- By:
- Publication type:
- Article
Analysis of immune‐related adverse events caused by immune checkpoint inhibitors using the Japanese Adverse Drug Event Report database.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2020, v. 29, n. 10, p. 1279, doi. 10.1002/pds.5108
- By:
- Publication type:
- Article
Pharmacokinetics of Favipiravir in Critically Ill Patients With COVID‐19.
- Published in:
- CTS: Clinical & Translational Science, 2020, v. 13, n. 5, p. 880, doi. 10.1111/cts.12827
- By:
- Publication type:
- Article
Safety and efficacy evaluation of low-dose trimethoprim-sulfamethoxazole for prophylaxis of Pneumocystis pneumonia in HIV uninfected patients undergoing hemodialysis: a retrospective observational study.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Time Course of Calcium Concentrations and Risk Factors for Hypocalcemia in Patients Receiving Denosumab for the Treatment of Bone Metastases From Cancer.
- Published in:
- Annals of Pharmacotherapy, 2014, v. 48, n. 9, p. 1159, doi. 10.1177/1060028014539919
- By:
- Publication type:
- Article